Lumin was orally administered to mice daily for 3 d, and on the day following the final administration, mice were sacrificed and splenocytes were stimulated with lipopolysaccharide (LPS). Splenocytes obtained from lumin-treated mice showed enhanced production of interferon g g (IFN-g g) and increased percentages of CD3 ؉ cells. Although T cells are considered to be the source of IFN-g g, it is unlikely that LPS directly stimulates T cells. Next we performed neutralization experiments using a monoclonal antibody (mAb) against interleukin (IL-)12 because this cytokine, which is produced by macrophages, has the direct ability to induce IFN-g g production and the proliferation of activated T cells. This antibody inhibited IFN-g g production by splenocytes. We thus show that orally administered lumin enhances IFN-g g production by splenocytes when the latter are stimulated with LPS, a phenomenon that was observed in correlation with activation of T cells by IL-12, that is produced by macrophages.
Dyestuffs have been investigated for their effect on the staining of bacteria and tissues because of their chromatic natures. In such studies, it was found that the azo dye prontosil is also effective in the treatment of infections. In actual fact, sulfa drugs were discovered based on these mechanisms and are now well established in the treatment of certain infections.
1) The photosensitizers, dyes for photo-emulsions, have been reported to have antibacterial effects, 2) antitumor effects 3) and therapeutic anti-allergic effects. 4, 5) These chemicals can absorb energy from light of a particular wavelength and release it in a different form. Thus, tissues or cells that preferentially take up photosensitizers will be more susceptible to the effects of these chemicals because of their preferential accumulation in such tissues.
The cationic cyanine dye lumin is an oral therapeutic agent used in Japan to promote wound healing. It is known to be a fluorescent antioxidant drug, 6) and it has been reported to have antitumor effects, 7) immunopotentiating effects 8) and to enhance the Fc-receptor-mediated phagocytic activity of macrophages. 6) However, little is known about the mechanism of how lumin acts to regulate immunological pathways in vivo. Moreover, most of the limited data on lumin has been generated from in vitro studies and there are only a very few reports where lumin was administered to experimental animals via the oral route.
In this report, we describe the effects of lumin on interferon g (IFN-g) production by splenocytes obtained from mice which had been administered the drug. The cellular mechanisms involved, including possible changes in the percentages of splenic cell populations induced by lumin via the oral route, were examined with respect to changes in IFN-g production.
MATERIALS AND METHODS

Mice and Reagents
Male BALB/c mice were purchased from Charles River Japan (Kanagawa, Japan). Lumin (4,4Ј- Fig. 1 ) is a product of Hayashibara Biochemical Laboratories Inc., (Okayama, Japan). Anti-mouse interleukin (IL-)12 monoclonal antibody (mAb, IgG2a k) was obtained from Dr. Okamura (Hyogo School of Medicine, Hyogo, Japan), and had been produced as described. 9, 10) Control mouse IgG2a mAb was obtained after immunizing animals with unrelated antigen and purification according to standard methods. Lipopolysaccharide (LPS, Difco, Detroit, MI, U.S.A.), purified hamster antimouse CD3e mAb (clone 145-2C11, CEDARLANE, Ontario, Canada), biotin-conjugated anti-mouse CD19 mAb (clone 1D3, PharMingen, CA, U.S.A.), biotin-conjugated anti-mouse pan-NK cells mAb (clone DX5, 11) PharMingen), biotin-conjugated anti-mouse macrophage mAb (clone F4/80, 12) Caltag Laboratories, CA, U.S.A.), fluorescein isothiocyanate (FITC)-conjugated avidin (Santa Cruz Biotechnology, CA, U.S.A.), and FITC-conjugated anti hamster IgG mAb (CEDARLANE) were obtained commercially.
Administration of Lumin Lumin was dissolved in saline at 20 mg/ml in the presence of a 200-fold concentration of sodium bicarbonate to facilitate dissolution. The agent in saline was administered to mice daily for 3 d via the oral route. On the day following the final administration, mice were sacrificed and splenocytes were subjected to various experimental procedures. Control vehicle-treated mice were administered the same concentration of sodium bicarbonate.
Cytokine Production Assay Spleens were removed from each BALB/c mouse and single cell suspensions were Biol. Pharm. Bull. 25(8) 1018-1021 (2002) Vol. 25, No. 8
prepared. After centrifugation, cells were treated with Tris ammonium chloride (ACT) buffer, pH 7.65, on ice to lyse red blood cells (RBC), and the remaining splenocytes were washed three times with RPMI 1640 medium containing 10% FBS and 10 mM HEPES. Splenocytes were resuspended in the same medium to a cell density of 1ϫ10 6 cells/ml. Cell suspensions were stimulated with 5 mg/ml of LPS in the presence of various concentrations of a neutralizing mAb against IL-12. After incubation for 72 h at 37°C, supernatants were collected and cytokine levels were determined by specific sandwich enzyme-linked immunosorbent assays (ELISA). The remaining cells were pulsed with 0.5 mCi of [ 3 H]thymidine overnight at 37°C. Cells were harvested onto glass-fiber filter papers, and the incorporated thymidine was determined by a Direct Beta Counter, Matrix 96 (Packard, Meridian, CT, U.S.A.).
Cell Surface Marker Analysis To identify changes in populations of cells expressing various cell surface markers, LPS-stimulated or unstimulated murine splenocytes were examined by flow cytometry. Oneϫ10 6 cells were incubated with mAbs specific for various cell surface markers for 30 min, followed by FITC-conjugated complementary second antibody for 30 min. All incubations were performed on ice and cells were washed twice with 200 ml of staining buffer (PBS containing 0.5% BSA and 0.1% sodium azide) between incubations. The stained cells were analyzed by flow cytometry on an EPICS XL cytometer (Coulter Electronics Inc., Hialeah, FL, U.S.A.).
Statistical Analysis Statistical comparisons between the experimental groups were performed by one-way analysis of variance (one way ANOVA), and each group was compared with the control group by the Dunnett test.
RESULTS
Effects of Lumin on IFN-g g Production by LPS-Stimulated Murine
Splenocytes LPS-stimulated, erythrocytefree untreated murine splenocytes produce a small amount of IFN-g. BALB/c mouse splenocytes produced 0.41 IU/ml of IFN-g when stimulated with 5 mg/ml of LPS for 72 h. However, splenocytes obtained from mice which had been administered 1000 mg/kg lumin via the oral route produced 2.72 IU/ml of IFN-g. The increase in IFN-g production depends on the concentration of lumin, ranging from 1 to 1000 mg/kg in our experiments ( Fig. 2A) . [ 3 H]Thymidine uptake also increased in correlation with IFN-g production (Fig. 2C) . On the other hand, there was no detectable difference in IL-6 production regardless of the concentrations of lumin administered (Fig. 2B) . IL-2, IL-10 and IL-12 were not detectable with sensitive ELISAs under these conditions (data not shown). Induction of peak IL-2 levels in unseparated lymphoid cell populations occurs 12-24 h after stimulation with appropriate mitogens. 13, 14) Thus IL-2 levels were determined not only after culture for 72 h but also after culture for 20 h, however, the cytokine was not detected (data not shown).
Changes in the Cellular Constitution of Lumin-Treated Mouse Spleens To assess the changes in the populations of the various immunocompetent cells and their ratios in lumintreated mouse spleens, namely the expression of CD3, CD19, the NK cell marker DX5, and the macrophage marker F4/80, we performed flow cytometric analysis. Since [ 3 H]thymidine uptake increased with increasing IFN-g production, we hypothesized that there may be changes in the cellular compositions of spleens from mice treated with lumin. As shown in Fig. 3 and Table 1 , the percentages of CD3 ϩ cells increased in LPS-stimulated splenocytes obtained from mice which had been administered lumin at 1000 mg/kg (57.1%) compared with the vehicle group. In LPS-stimulated splenocytes obtained from vehicle-treated mice, the percentage of CD3 ϩ B cells, NK cells and macrophages, were also unchanged (data not shown).
Effects of IL-12 Neutralizing mAb on IFN-g g Production by Lumin-Treated Mouse Splenocytes
It is generally accepted that LPS does not stimulate T cells directly, but does so indirectly through stimulation of B cells and macrophages. However, we found that IFN-g production and the proliferation of the spleen CD3 ϩ cell population were similarly upregulated when splenocytes obtained from lumin- 
. Effect of Lumin on the Proliferation of Murine Splenocytes and Cytokine Production by the Cells
Murine splenocytes obtained from untreated mice or mice which had been administered lumin were stimulated with LPS for 72 h. Culture supernatants were collected and IFN-g (A) and IL-6 (B) levels were determined by specific sandwich ELISAs. The remaining cells were pulsed with [ 3 H]thymidine over-night at 37°C and the incorporated thymidine was determined by a beta counter (C). The data shows results of one representative experiment of four similar experiments. A statistically significant difference between the means of experimental and control groups was observed, * pϽ0.05. treated mice were stimulated in vitro with LPS. Accordingly we were of the opinion that these upregulations were not the direct effects of lumin on T cells but the indirect effects through B cells or macrophages. To assess the participation of macrophages, we performed neutralization experiments using a mAb against IL-12. As shown in Fig. 4 , 25 mg/ml of a mAb against murine IL-12 completely inhibited LPS-induced in vitro IFN-g production by splenocytes obtained from lumin-treated mice. However these phenomena were not observed in the vehicle-treated group.
DISCUSSION
For a considerable number of years, it has been thought that photosensitizers enhance corrective biological responses in organs. This is attributed to the faculty of improving immune responses exhibited by photosensitizers, and investigators are particularly interested in the functional mechanisms of macrophage activation. We have administered lumin to mice and investigated the activation of immune responses, especially IFN-g production.
Splenocytes obtained from mice which had been administered lumin via the oral route were stimulated with LPS for 72 h in vitro. Culture supernatants were then collected and cytokine levels were determined by specific sandwich ELISA. As a result, it was observed that IFN-g production increased depending on the dose of lumin. At the same time, [ 3 H]thymidine uptake also increased in parallel with IFN-g production. However, there were no detectable differences between the IL-6 productions by splenocytes from lumin-administered mice and vehicle-treated mice. Accordingly, it was considered that the cell population that is mainly responsible for production of IFN-g was likely to be activated. Therefore we performed flow cytometric analysis using mAbs against cell surface markers to determine their expression by immunocompetent cells in the spleen. As a result, we observed that the percentage of CD3 ϩ cells in the total number of splenocytes had increased. It is unlikely that LPS directly stimulated the CD3 ϩ cells, namely the T cells, and we considered that this phenomenon was probably generated by a secondary stimulus through B cells and macrophages which are known to be stimulated by LPS.
Subsequently, we measured the levels of factors that are known to activate T cells. IL-2 is cited as a typical cytokine that induces the proliferation and differentiation of T cells. 15) However, IL-2 levels were not detectable under our experimental conditions. On the other hand, IL-12 has the direct ability to induce IFN-g production and the proliferation of activated T cells. 16 ) Therefore, we examined the influence of a neutralizing mAb against IL-12 on IFN-g production when lumin-treated mouse splenocytes were stimulated with LPS. As a result, anti-IL-12 mAb inhibited IFN-g production by splenocytes. However, similar patterns of IFN-g production were observed between the lumin-administered mice and control vehicle-treated mice. IL-12, which is mainly produced by macrophages, induces IFN-g production by T cells. Therefore under our conditions of stimulation with LPS, it was thought that T cells were stimulated via IL-12 which had been produced by macrophages, resulting in the production 1020 Vol. 25, No. 8 The neutralizing mAb was added when lumin-treated mouse splenocytes were stimulated with LPS. "Ct." indicates the control antibody substituted for anti-IL-12 mAb. Culture supernatants were collected and IFN-g levels were determined by specific sandwich ELISA. A statistically significant difference between the mean IFN-g levels of experimental and control groups was observed, * pϽ0.01. Splenocytes obtained from mice which had been administered lumin (1000 mg/kg) or vehicle only were analyzed by flow cytometry before or after stimulation with LPS. The data shows results of one representative experiment of five similar experiments.
of IFN-g. Yamamoto et al. reported that the peritoneal macrophages of mice exhibited an enhanced ingestion activity after administration of lumin via the intraperitoneal route. 6) Also in the case of oral administration, it may be that macrophages are activated and that sensitivity to a stimulus such as LPS was up-regulated by lumin. Whether or not this is so, it appears that lumin induces the activation of immunocompetent cells in these processes, and we intend to analyze this further.
In conclusion, it was revealed that orally administered lumin enhances IFN-g production by splenocytes stimulated with LPS. This phenomenon was observed in correlation with the activation of T cells by IL-12, which is produced by macrophages.
